Renal Denervation Devices Market Trends Supporting 32.4% CAGR Growth Through 2030
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Renal Denervation Devices Market Set To Climb From $0.98 Billion In 2026 To $3.01 Billion By 2030
The renal denervation devices market has experienced significant expansion over the past few years. It will grow from $0.74 billion in 2025 to $0.98 billion in 2026 at a compound annual growth rate (CAGR) of 32.5%. Historical growth has stemmed from the increasing prevalence of resistant hypertension, progress in catheter ablation technologies, a rise in clinical research related to renal denervation, the expansion of interventional cardiology procedures, and greater awareness of non-pharmacological treatments for hypertension.
The renal denervation devices market is expected to demonstrate significant growth in the coming years, with projections indicating it will reach a value of $3.01 billion by 2030, expanding at a compound annual growth rate (CAGR) of 32.4%. This anticipated growth throughout the forecast period can be attributed to several factors, including an increase in regulatory approvals for renal denervation devices, their rising adoption in outpatient environments, an escalating demand for long-term solutions for hypertension management, the expansion of clinical evidence supporting their efficacy, and greater investment in next-generation ablation systems. Prominent trends for this period encompass the increasing uptake of catheter-based therapies for hypertension, a broader application of radiofrequency and ultrasound ablation technologies, a heightened focus on minimally invasive cardiovascular interventions, an increase in image-guided renal denervation procedures, and a stronger emphasis on ensuring procedure safety and precision.
Get A Free Sample Report With In-Depth Market Insights:
Renal Denervation Devices Market Expansion Drivers: What’s Shaping Future Growth?
The future growth of the renal denervation devices market is expected to be propelled by the increasing prevalence of hypertension. Hypertension, or high blood pressure, signifies a condition where blood flows through vessels with consistently excessive force. Renal denervation, a catheter-based procedure, has emerged as a potential therapeutic solution for patients with resistant hypertension. This minimally invasive, investigational procedure aims to treat hypertension that has not responded to medication. For illustration, in January 2025, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2023, high blood pressure contributed to or directly caused 664,470 deaths in the United States. Therefore, the rising prevalence of hypertension will significantly drive the expansion of the renal denervation devices market.
Renal Denervation Devices Market Segment Trends And Revenue Contributors
The renal denervation devices market covered in this report is segmented –
1) By Product: Simplicity Renal Denervation System, EnligHTN, Vessix Renal Denervation System, Iberis Renal Sympathetic Denervation System, Paradise Renal Denervation System, Other Products
2) By Technology: Radio Frequency Ablation, Ultrasound Energy-Based RDN, Other Technologies
3) By End-Users: Hospitals, Cardiovascular research centre, Other End-Users
Subsegments:
1) By Simplicity Renal Denervation System: Catheter System, Accessories
2) By EnligHTN: Catheter System, Generator, Accessories
3) By Vessix Renal Denervation System: Balloon Catheter, Generator, Accessories
4) By Iberis Renal Sympathetic Denervation System: Catheter System, Accessories
5) By Paradise Renal Denervation System: Catheter System, Accessories
6) By Other Products: Emerging Technologies, Alternative Devices
Renal Denervation Devices Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies within the renal denervation devices market are concentrating on the development of ultrasound renal denervation (uRDN) to improve treatment effectiveness, reduce procedural complications, and offer a non-invasive alternative to traditional renal denervation techniques. Ultrasound renal denervation (uRDN) enhances renal denervation devices by enabling precise, non-surgical energy delivery to renal nerves, which effectively lowers blood pressure while safeguarding nearby tissues and increasing patient safety and comfort during the procedure. For example, in November 2023, Recor Medical Inc., a US-based medical technology company, launched the Paradise uRDN system, an innovative ultrasound renal denervation device designed to manage hypertension in patients who have not achieved blood pressure targets with standard lifestyle changes and medications. Featuring hydrocooling technology to protect the renal artery during treatment, this system marks a significant advancement in the renal denervation devices market by introducing a new, nonpharmacologic approach to managing resistant hypertension and expanding treatment options for patients.
Renal Denervation Devices Market Competitive Overview And Top Companies
Major companies operating in the renal denervation devices market are Medtronic PLC, ReCor Medical Inc., Boston Scientific Corporation, Abbott Laboratories, Cordis Corporation, Terumo Corporation, Kona Medical Inc., St. Jude Medical LLC, Johnson & Johnson, Symple Surgical Inc., Cardiosonic Ltd., Mercator MedSystems Inc., Ablative Solutions Inc., Renal Dynamics Ltd., Vesalio LLC, Biotronik SE & Co. KG, Cook Medical LLC, Hansen Medical Inc., Merit Medical Systems Inc., AngioDynamics Inc., Covidien Ltd., Volcano Corporation
View The Full Renal Denervation Devices Market Report:
Renal Denervation Devices Market Top Region: Where Does Most Revenue Come From?
Europe was the largest region in the renal denervation devices market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global renal denervation devices market report during the forecast period. The regions covered in the renal denervation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
